Koyfin Home > Directory > Health Care > Acorda Therapeutics > Net Debt / EBITDA

Acorda Therapeutics Net Debt / EBITDA Chart (ACOR)

Acorda Therapeutics annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Acorda Therapeutics Net Debt / EBITDA for the quarter ending June 06, 2020 was $-4m a 60.82% decrease of -3m year over year
  • Acorda Therapeutics Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $-4m a 57.14% decrease of -2m year over year
  • Acorda Therapeutics Annual Net Debt / EBITDA for 2019 was $-2m a 45.81% decrease of -1m from 2018
  • Acorda Therapeutics Annual Net Debt / EBITDA for 2018 was $-1m a 121.44% decrease of -1m from 2017
  • Acorda Therapeutics Annual Net Debt / EBITDA for 2017 was $0m a -6,971.40% decrease of -14m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Net Debt / EBITDA Data

06/2020$-4m
03/2020$-2m
12/2019$37m
09/2019$-2m
06/2019$-1m
03/2019$0m
12/2018$2m
09/2018$-1m
06/2018$0m
03/2018$0m

Annual ACOR Net Debt / EBITDA Data

2019$-2m
2018$-1m
2017$0m
2016$15m
2015$-1m
2014$0m
2013$-7m
2012$-8m
2011$-5m
2010$52m